September 23, 2020 by Jeffrey Woldt
Dark & Lovely, L’Oréal USA Consumer Products division, Nathalie Gerschtein
Leading Headlines, September 21, 2020, Supplier News
The outbreak of COVID-19 at the start of the year and subsequent efforts to control the virus created much uncertainty in the beauty care business, but did little to disturb the preeminence of L’Oréal. Under the direction of president Nathalie Gerschtein, the L’Oréal USA Consumer Products division adapted quickly to changing dynamics in the marketplace,
September 21, 2020 by Todd Huseby, Rodey Wing and Emily Rowe
coronavirus (COVID-19), health care, health care costs, pharmacy benefit manager (PBM)
Pharmacy, September 21, 2020
Today’s retail pharmacies face increasing pressure from all fronts. Governments are aiming to reduce health care costs, and public sentiment is pushing the industry toward a value-based model. The use of high-cost specialty drugs is increasing dispensing complexity and shifting channel volume — at a time when disruptors like Amazon are poised to impact pricing.
September 21, 2020 by Chain Drug Review
Jeff Leger, Shoppers Drug Mart
News, September 21, 2020
TORONTO — Jeff Leger, president of Shoppers Drug Mart, Canada’s largest drug chain, discussed recent developments at the company including the launch of Shoppers’ first freestanding health clinic, the retailer’s innovative home health care and beauty clinic formats with Chain Drug Review editor-in-chief, Jeffrey Woldt, in a video forum hosted by CDR and sister publication
September 21, 2020 by Chain Drug Review
COVID-19 vaccine
News, September 21, 2020
NEW YORK — The effort to develop a safe and effective vaccine for COVID-19 has been an all-hands-on-deck approach ever since the virus began wreaking havoc across the globe earlier this year. But it seems now, with the presidential election less than two months away — and with President Trump promising a vaccine “very soon”
September 21, 2020 by Chain Drug Review
COVID-19, COVID-19 vaccine, Department of Health and Human Services' (HHS) proposed rule permitting prescription drug importation
News, September 21, 2020
WASHINGTON — The Department of Health and Human Services (HHS) this month authorized pharmacists to order and administer COVID-19 vaccination, a move welcomed by pharmacy advocates. “This is an extremely important decision by the administration,” said National Association of Chain Drug Stores president and chief executive officer Steve Anderson. “When safe and effective COVID-19 vaccinations
September 21, 2020 by David Pinto
John Standley, Stefano Pessina, Walgreens
Opinion, September 21, 2020
As the least-revered year 2020 winds down, several questions emerge regarding the future of chain drug retailing in America. It’s not that the industry is shaky or uncertain going forward; rather it’s that America’s chain drug industry has changed — perhaps permanently. A scenario that was unimaginable a year ago now presents itself as a
September 21, 2020 by Jeffrey Woldt
Doug McMillon, Walmart
Opinion, September 21, 2020
In a recent video marking the first anniversary of the Business Roundtable’s adoption of a revised statement of purpose for a corporation, Walmart CEO Doug McMillon spoke about how the new definition — which was expanded from a tight focus on shareholders to one that also includes customers, employees, suppliers and communities — reflects the
September 21, 2020 by Jeffrey Woldt
global sustainability, Jeffrey Woldt editor-in-chief Chain Drug Review
Opinion, September 21, 2020
CDR SPECIAL REPORT — Since the beginning of the COVID-19 pandemic, the momentum behind the sustainability movement has slowed somewhat, with the attention of government officials, activists and average citizens dominated by the immediate crisis and the concurrent drive for racial justice. The climate emergency has not, however, abated, a reality brought home to Americans